Revance Therapeutics Inc (RVNC)

[alertmeipp]

The headline was a miss, 59 vs 51 actual

But the CC was actually not bad, they mentioned April and first part of May was doing well.

And sales can now focus more on cross selling and new accounts acquisition rather than just fixing the premium price issue

They actually also gave reference to last q1 q2 growth rate (which was almost 50 percent)

Too early to really tell but pps priced for much worse I think